加拿大FoodNet哨点肠道细菌感染抗生素处方实践分析
本研究通过环境扫描汇总10部肠道细菌感染治疗指南,并分析2010—2018年加拿大三个哨点5877例实验室确诊肠道细菌感染病例的抗生素处方数据。结果显示指南推荐差异大,49%病例接受抗生素处方,产vero毒素大肠埃希菌病例中21%接受处方,实践中使用了指南推荐的17种抗生素中的14种,另有18种指南未收录的抗生素被处方。
要点
- 肠道细菌感染中49%病例接受抗生素处方,产vero毒素大肠埃希菌病例中21%接受处方。
- 10部指南在是否处方及推荐药物上存在显著差异。
- 实践中使用了14种指南推荐抗生素,另有18种指南外抗生素被处方。
核心结论
- 加拿大肠道细菌感染中相当比例病例被处方抗生素,指南推荐差异大且实践与指南存在不一致。
研究设计与样本
- 环境扫描汇总肠道细菌感染治疗指南,并对FoodNet Canada三个哨点2010—2018年5877例实验室确诊肠道细菌感染病例进行描述性分析,抗生素使用数据由病例通过增强问卷自我报告。
主要发现
- 共识别10部治疗指南,指南间在何时处方及推荐何种抗生素上存在显著差异。
- 5877例实验室确诊肠道细菌感染病例中49%报告接受抗生素处方。
- 产vero毒素大肠埃希菌病例中21%接受抗生素处方。
- 指南推荐的17种抗生素中14种在实践中有使用,另有18种指南未收录的抗生素也被处方。
关键数值与推荐
- 10部指南间在处方指征和推荐药物上存在显著差异。
- 5877例中49%接受抗生素处方。
- 产vero毒素大肠埃希菌病例中21%接受处方。
- 指南推荐17种抗生素,实践中使用14种,另有18种指南外抗生素被处方。
临床怎么用
- 应标准化肠道细菌感染治疗指南以减少实践差异。
- 产vero毒素大肠埃希菌病例的高处方率需引起关注并优化管理。
- 研究结果可用于指导未来抗菌药物管理计划的制定。
局限性
- 抗生素使用数据由病例自我报告,可能存在回忆偏倚。
- 仅纳入三个哨点,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Understanding the current state of antibiotic treatment guidelines and prescribing practices for bacterial enteric infections is critical to inform antibiotic stewardship initiatives. This study aims to add to the current understanding through three objectives: (i) to identify and summarize published treatment guidelines for bacterial enteric infections; (ii) to describe observed antibiotic prescribing practices for bacterial enteric infections across three sentinel sites in Canada; and (iii) to assess concordance between observed antibiotic prescribing and treatment guidelines. METHODS: An environmental scan of treatment guidelines for bacterial enteric infections was conducted and recommendations were collated. A descriptive analysis of cases of bacterial enteric illnesses captured in FoodNet Canada's sentinel site surveillance system between 2010 and 2018 was performed. Antibiotic-use data were self-reported by cases via an enhanced questionnaire. RESULTS: Ten treatment guidelines were identified in the environmental scan. There was substantial variation between guidelines for both when to prescribe antibiotics and which antibiotics were recommended. Of the 5877 cases of laboratory-confirmed bacterial enteric illness in the three sites, 49% of cases reported having received an antibiotic prescription. Of particular significance was the finding that 21% of verotoxigenic Escherichia coli cases received a prescription. Of the 17 antibiotics recommended in the guidelines, 14 were used in practice. In addition to these, 18 other antibiotics not included in any of the guidelines reviewed were also prescribed. CONCLUSIONS: Our study suggests that a substantial proportion of enteric bacterial infections in Canada are prescribed antibiotics. These findings highlight the need to standardize treatment guidelines for enteric illnesses and could be used to inform future stewardship programme development.
引用
- Dougherty B, Finley R, Marshall B, et al. An analysis of antibiotic prescribing practices for enteric bacterial infections within FoodNet Canada sentinel sites. J Antimicrob Chemother. 2020. PMID: 31960039. doi:10.1093/jac/dkz525
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。